Designing Trust for a Global Leader
Industry: Biotechnology Research
Service: Corporate Communications
Background:
Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on developing and delivering high-quality medicines for people living with rare metabolic diseases. Founded on empathy and innovation, Amicus operates with a mission-driven culture that integrates the patient perspective into every aspect of its work.
Challenge:
As a global leader in rare disease innovation, Amicus sought to clearly communicate its values and ongoing commitment to ethical business practices, inclusion, and sustainability through its Environmental, Social, and Governance (ESG) Report. The company needed a partner capable of organizing complex data, illustrating impact, and presenting its story with transparency and heart.
Solution:
LGC provided the full creative direction, design development, and visual structure—resulting in a strategically organized and visually compelling publication that reflects the company’s dedication to patients and global responsibility